Sign in
Taking peopleNo phase

Simulation-Free Single-Fraction Radiation Therapy for Indolent Lymphoma

Key facts

Who runs it
University Health Network, Toronto
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
9 Oct 2026
Expected to end
31 Dec 2028
Type of study
Interventional
Treatments tested
  • Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)
Record updated
18 November 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Histologically confirmed indolent B-cell lymphoma, including marginal zone/mucosa-associated lymphoid tissue (MALT) lymphoma, follicular lymphoma grades 1-2, small lymphocytic lymphoma, or mantle cell lymphoma
  • Disease requiring focal radiation therapy with 4 Gy delivered in one fraction for local control or symptom relief
  • Lesion anatomy suitable for single-fraction radiation therapy and simulation-free, CBCT-guided treatment delivery, as determined by the treating radiation oncologist
  • Available diagnostic CT imaging suitable for contouring and dose calculation that encompasses the full intended target and relevant organs at risk:
  • Obtained within 2 months before treatment for orbital or ocular adnexal disease
  • Obtained within 6 weeks before treatment for non-orbital disease
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-3, with the ability to tolerate treatment positioning and delivery
  • Localized or advanced-stage disease is permitted, provided the target lesion is appropriate for focal treatment

Who cannot take part

  • Prior radiation therapy to the same site if re-irradiation using the study workflow is considered clinically inappropriate
  • Disease anatomy unsuitable for simulation-free delivery, such as inability to maintain stable positioning, excessive motion, or inadequate CBCT visualization
  • Bulky disease greater than 6 centimeters for which single-fraction 4 Gy radiation therapy is unlikely to provide adequate local control, as determined by the treating physician
  • Requirement for urgent systemic therapy because of widespread or symptomatic disease
  • Diagnostic imaging that does not meet the minimum quality requirements for treatment planning or falls outside the required time window

This trial is currently available in Canada.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This pilot study will evaluate whether people with indolent B-cell lymphoma can receive radiation therapy without a separate computed tomography (CT) simulation appointment. Participants will receive one low-dose radiation treatment of 4 gray (Gy). Treatment planning will use a recent diagnostic CT scan, and cone-beam computed tomography (CBCT) imaging on the treatment day will be used to confirm participant positioning and adjust the treatment plan if needed.

Read full original descriptionShow less

The study includes participants with orbital or ocular adnexal lymphoma and participants with lymphoma at other body sites. The investigators will assess whether simulation-free treatment can be completed successfully, treatment duration, the number of hospital visits required, treatment side effects, patient-reported symptoms, control of the treated lymphoma site, and the need for additional treatment. Participants will be followed for up to 12 months.

The group in the trial

  • Simulation-Free Single-Fraction Radiation TherapyTreatment being tested

    Participants will receive simulation-free, cone-beam computed tomography (CBCT)-guided adaptive radiation therapy delivered as a single 4 gray (Gy) fraction. Treatment planning will use a recent diagnostic computed tomography (CT) scan instead of a separate planning CT simulation. CBCT imaging will be obtained on the treatment day to confirm positioning and anatomy and to adapt the treatment plan when needed. Participants for whom the simulation-free workflow is not feasible will proceed to standard CT simulation-based treatment.

    Treatment: Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)

Next steps

For your doctor

Doctor ask sheet

A PDF summary of this trial for your doctor: what it tests, who can take part, its registry number and links, with room for notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SIMulation-free Protocols for Lymphoma RadiotherapY [SIMPLY]
Record updated
18 November 2026